Anesthesiology

ISSN
P 0003-3022 E 1528-1175
출판사
Lippincott Williams & Wilkins Ltd.
국가
USA
발행 상태
활성

데이터베이스 수록 정보

CiteScore 2011-2025 (15년)
EMBASE 2016-2026 (11년)
JCR 1997-2025 (29년)
MEDLINE 2016-2024 (9년)
SCI 2010-2019 (10년)
SCIE 2010-2026 (17년)
Scopus 1942-1943, 1945-2026 (84년)
SJR 1999-2020, 2022-2025 (26년)

전체 23건 중 1번부터 10번까지의 결과를 표시합니다.

2025
Article

Real-world evidence of first-or second-line immune checkpoint inhibitors versus chemotherapy in advanced NSCLC: A prospective pragmatic multicenter Korean study

  • Kim, J.
  • Park, S.
  • Lee, G- W.
  • Kim, I. H.
  • Kim, D- W.
  • 외 12명
  • 2025-12
  • Annals of Oncology
  • Oxford University Press
2024
Article

Exploratory biomarker analysis in EGFR mutated NSCLC patients who treated with atezolizumab plus bevacizumab and chemotherapy from phase III ATTLAS trial

  • Kim, H.
  • Park, S.
  • Kim, T. M.
  • Han, J-Y.
  • Lee, G-W.
  • 외 12명
  • 2024-12
  • Annals of Oncology
  • Oxford University Press
Article

Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)

  • Yoo, C.
  • Kim, H-D.
  • Chon, H. J.
  • Sym, S. J.
  • Kim, M.
  • ... Kang, J. H.
  • 외 9명
  • 2024-12
  • Annals of Oncology
  • Oxford University Press
2023
Article

Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)

  • Huh, S. J.
  • Oh, S. Y.
  • Kang, J. H.
  • Go, S-I.
  • Lee, S.
  • 외 1명
  • 2023-10
  • Annals of Oncology
  • Oxford University Press
Article

A phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)

  • Ahn, M. J.
  • Park, S.
  • Kim, T. M.
  • Han, J. Y.
  • Lee, G. W.
  • 외 12명
  • 2023-10
  • Annals of Oncology
  • Oxford University Press
1